GlaxoSmithKline plc

    2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986
Revenue £34.11B£34.1B£33.75B£30.82B£30.19B£27.89B£23.92B£23.01B£26.5B£26.43B£27.39B£28.39B£28.37B£24.35B£22.74B£23.22B£21.66B£20.35B£21.41B£21.21B£20.53B£18.08B£8.49B£7.98B£7.98B£8.34B£10.49B£6.48B£5.66B£4.93B£4.1B£3.4B£3.18B£2.57B£2.06B£1.74B£1.43B
Cost of Revenue £11.6B£11.7B£11.86B£10.24B£10.34B£9.29B£8.85B£7.32B£8.59B£7.89B£7.33B£7.59B£7.38B£6.42B£5.21B£5.01B£4.76B£4.31B£4.54B£4.61B£4.44B£3.96B£4.33B£1.54B£0£0£0£904.11M£0£0£0£0£0£0£0£0£0
Gross Profit £22.51B£22.39B£21.89B£20.58B£19.84B£18.6B£15.07B£15.68B£17.92B£18.54B£20.05B£20.8B£20.99B£17.94B£17.53B£18.21B£16.89B£16.04B£16.88B£16.6B£16.09B£14.12B£4.16B£6.44B£0£0£0£5.58B£0£0£0£0£0£0£0£0£0
Gross Profit Margin 65.99%65.68%64.85%66.77%65.74%66.69%62.99%68.17%67.61%70.13%73.23%73.26%73.98%73.66%77.08%78.43%78%78.84%78.81%78.27%78.38%78.09%48.95%80.65%0%0%0%86.05%0%0%0%0%0%0%0%0%0%
Operating Expenses £16.31B£16.17B£15.6B£13.52B£13.78B£12.57B£12.44B£11.38B£12.02B£12.37B£12.84B£17.02B£12.56B£10.8B£9.33B£10.4B£16.53B£9.9B£10.49B£9.91B£9.99B£10.7B£1.36B£3.78B£5.08B£5.21B£6.92B£4.12B£3.84B£3.41B£2.8B£3.4B£3.18B£2.57B£2.06B£1.74B£1.43B
Research & Development Expenses (R&D) £5.28B£5.1B£4.57B£3.89B£4.48B£3.63B£3.56B£3.45B£3.92B£3.97B£4.01B£4.46B£4.11B£3.68B£3.24B£3.46B£3.14B£2.84B£2.79B£2.9B£2.56B£2.53B£1.27B£1.16B£1.15B£1.16B£1.54B£0£858M£739M£595M£475M£420M£323M£230M£149M£113M
Selling, General & Administrative Expenses (SG&A) £10.97B£11.46B£11.4B£9.91B£9.67B£9.37B£9.23B£8.25B£8.48B£8.74B£8.83B£13.05B£9.59B£7.66B£13.64B£14.51B£7.25B£7.06B£7.57B£8.04B£7.47B£0£0£0£0£0£0£3.79B£0£0£0£0£0£0£0£0£0
Other Expenses £57M£-383M£-371M£-292M£-365M£-421M£-350M£-319M£-387M£-336M£0£-493M£-1.14B£-541M£-7.55B£-7.56B£6.14B£0£133.28M£-1.03B£-37.16M£8.17B£88M£2.62B£3.94B£4.05B£5.38B£330.42M£2.98B£2.67B£2.21B£2.92B£2.76B£2.25B£1.83B£1.59B£1.32B
Net Income £4.38B£5.75B£4.64B£3.62B£1.53B£912M£8.42B£2.76B£5.44B£4.57B£5.26B£1.63B£5.53B£4.71B£5.22B£5.39B£4.69B£4.3B£4.48B£3.94B£3.1B£4.16B£1.81B£1.84B£1.85B£2B£1.46B£1.04B£1.3B£1.21B£1.03B£881M£807M£688M£581M£510M£400M
Net Profit Margin 12.85%16.86%13.76%11.75%5.08%3.27%35.2%11.98%20.51%17.27%19.21%5.76%19.5%19.35%22.95%23.2%21.65%21.13%20.91%18.55%15.1%23.02%21.33%23%23.18%23.94%13.9%16.04%22.97%24.48%25.22%25.93%25.39%26.77%28.22%29.29%27.99%
Operating Income £6.2B£7.78B£6.96B£5.48B£4.09B£2.6B£10.32B£3.6B£7.03B£7.39B£7.81B£3.78B£8.43B£7.14B£7.94B£7.81B£363.81M£6.15B£6.38B£5.55B£6.1B£4.73B£2.63B£2.68B£2.82B£3.13B£2.38B£1.45B£1.82B£1.52B£1.29B£0£0£0£0£0£0
Other Income & Expenses (Net) £-759M£-815M£-740M£-683M£-562M£-659M£204M£-629M£-381M£-700M£-109M£-626M£-534M£-482M£-402.39M£-9.19M£6.37B£-31.28M£-62.72M£-45M£-17.89M£1.3B£-50M£-12M£-136M£-168M£5M£62.1M£18M£150M£140M£0£0£0£0£0£0
Depreciation & Amortization £2.52B£2.35B£2.33B£1.86B£1.92B£1.77B£1.63B£1.48B£1.41B£1.45B£1.42B£1.68B£1.56B£1.23B£1.02B£958.04M£903.7M£890.48M£859.04M£824M£812.8M£735M£428M£358M£373M£410M£533M£330.42M£282M£225M£191M£151M£122M£93M£73M£55M£42M
Interest Income £28M£29M£98M£81M£63M£70M£99M£66M£59M£73M£90M£116M£70M£313M£262M£287M£257M£176M£0£73M£0£158M£114M£111M£104M£89M£250M£0£65M£186M£180M£242M£186M£0£0£0£0
Interest Expense £784M£856M£885M£771M£736M£717M£735M£703M£740M£760M£799M£831M£783M£843M£453M£352M£451M£362M£161M£206M£0£317M£206M£202M£227M£276M£337M£0£44M£56M£63M£75M£44M£26M£21M£11M£7M
Income Tax Expense £346M£580M£953M£754M£1.36B£877M£2.15B£137M£1.02B£1.95B£2.24B£1.3B£2.22B£1.95B£2.22B£2.3B£1.92B£1.7B£1.74B£1.46B£1.65B£1.75B£746M£815M£819M£933M£867M£476.61M£524M£461M£386M£359M£357M£316M£256M£245M£209M
Effective Tax Rate 6.36%8.32%15.32%15.71%38.47%45.23%20.46%4.62%15.33%29.11%29.1%41.31%28.16%29.24%29.47%29.51%28.46%27.8%27.47%26.53%27.12%28.98%28.97%30.51%30.49%31.48%36.32%31.44%28.56%27.52%27.05%27.98%30.2%31.41%30.77%32.84%34.15%
EBITDA £8.04B£9.54B£8.82B£7B£5.55B£4.28B£12.94B£5.08B£8.61B£8.72B£9.72B£5.45B£10.1B£8.73B£8.92B£9B£7.96B£7.25B£7.23B£6.43B£5.56B£6.96B£3.19B£3.21B£3.27B£3.62B£3.19B£1.85B£2.15B£1.95B£1.67B£1.47B£1.33B£1.12B£931M£821M£658M
EBIT £5.51B£7.18B£6.48B£5.15B£3.62B£2.51B£11.31B£3.6B£7.2B£7.27B£8.3B£3.77B£8.54B£7.5B£7.89B£8.04B£7.05B£6.36B£6.38B£5.6B£4.75B£6.23B£2.76B£2.85B£2.9B£3.21B£2.66B£1.52B£1.87B£1.72B£1.48B£1.31B£1.21B£1.03B£858M£766M£616M
EBT N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Shares Outstanding 2.5B2.49B2.47B2.46B2.44B2.43B2.42B2.4B2.42B2.46B2.51B2.55B2.53B2.62B2.76B2.82B2.84B2.87B2.9B2.96B3.04B3.03B1.81B1.8B1.78B1.76B1.64B1.58B1.52B1.51B1.51B1.5B1.5B744.86M740M740M740M
Diluted Shares Outstanding 2.53B2.52B2.51B2.49B2.47B2.45B2.44B2.43B2.46B2.49B2.55B2.56B2.55B2.63B2.78B2.85B2.86B2.87B2.92B2.98B3.06B3.07B1.82B1.82B1.8B1.76B1.64B1.58B1.52B1.51B1.51B1.5B1.5B744.86M740M740M740M
EPS £1.75£2.31£1.88£1.47£0.63£0.38£3.49£1.15£2.25£1.86£2.09£0.64£2.18£1.8£1.89£1.91£1.65£1.36£1.54£1.32£1.01£1.35£1£1.02£1.04£1.13£0.89£0.66£0.85£0.8£0.69£0.59£0.54£0.92£0.79£0.69£0.54
Diluted EPS £1.73£2.28£1.85£1.46£0.62£0.37£3.45£1.13£2.21£1.83£2.06£0.64£2.16£1.79£1.87£1.89£1.64£1.36£1.54£1.32£1£1.34£1£1.01£1.02£1.13£0.89£0.66£0.85£0.8£0.69£0.59£0.54£0.92£0.79£0.69£0.54

Copyright © 2022 STOCKROUTINES